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ABSTRACT  
Background: Non-small cell lung cancer (NSCLC) is the major cause of mortality all over the world. Significant increase of biglycan is seen i n 
the lung cancer cells when compared with the normal cells. It promotes tumor invasion and metastasis by activating Focal Adhesion Kinase 
(FAK) signaling pathway. The increased FAK activity may contribute to the metastatic potential of malignant tumors. This study was carried out 
to establish binding interactions of some selected phytocomponents against biglycan for the possible arrest of metastasis. 
Methods: Protein-ligand interaction studies were performed using 30 natural compounds from different culinary herbs having potential 
therapeutic role against the target protein biglycan (BGN).  
Molegro Virtual Docker (v 5.0) was used as docking tool to evaluate the effectiveness of selected phytocomponents based upon the interaction 
with the protein’s active site residues with minimal binding energy. Protein-protein docking was performed to observe the interaction of BGN 
and FAK using Hex (v 8.0.0). Molecular dynamics (10 ns) of BGN-RA-FAK and FAK-RA-BGN was performed in Yasara structure (v 17.8.15) 
which showed stability of the structure in terms of RMSD values. 
Results: Molecular docking analysis revealed the selectivity of Rosmarinic acid (RA) towards BGN and FAK. Molecular dynamics trajectory of 
BGN-RA-FAK and FAK-RA-BGN complexes showed the stability of structure in terms of Time vs Energy and Time vs RMSD values and revealed 
that binding of RA to BGN will block the interaction of FAK. 
Conclusions: Hence, investigating the binding interactions of BGN-RA-FAK complex may turn out to be helpful in arresting metastasis in 
NSCLC. 
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INTRODUCTION 
Lung cancer is the leading cause of cancer related deaths and 
non-small cell lung cancer (NSCLC) is the most frequent 
subtype comprising of 85% of recorded cases 1. According to 
the cancer facts and figures 2 of American cancer society, the 
five year survival rate for lung cancer is only 18%.  It 
constitutes about 6.9 per cent of all new cancer cases and 9.3 
percent of all cancer related deaths in both sexes in India 3 
and continues to be a major global health problem. The 
disease is diagnosed in more than 1.6 million new patients 
each year. However, significant progress is ongoing in both 
the prevention and treatment of lung cancer 4. Many 
integrated multidisciplinary approaches to the treatment of 
lung cancer have improved patient outcomes, but there is an 
urgent need for a novel therapeutic strategy for lung cancer 
as there is no breakthrough treatment with long-term 
efficacy 5. Specifically improved proteomics techniques for 
the identification, detection, and verification of biomarkers 
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have improved our understanding of lung cancer but, early 
detection of lung cancer is important for a better outcome 
and to decrease the lung cancer mortality rate 6, 7. 
Metastasis, the spread of cancer through lymph and blood, to 
distant organs is the main reason of death for most of the 
patients with malignancy 8. Hence, this study was aimed at 
employing an in silico approach to identify a specific binding 
interaction of Protein-Ligand-Protein for arresting 
metastasis in NSCLC. 
Biglycan (BGN) is a member of small leucine-rich 
proteoglycans family, and it has been ascribed a pivotal role 
in oncogenesis and development of various other types of 
human cancer. It is also an important component of the 
extracellular matrix 9. BGN is found in almost every organ in 
a non-uniform distribution pattern within human body. 
Recent studies have indicated that there is significant 
increase of BGN in tumor tissues as compared to normal 
tissues, in several cancer types. It is known as a multivalent 
proteoglycan which promotes tumor invasion and 
metastasis by activating the Focal Adhesion Kinase (FAK) 
signaling pathway. The increased FAK activity may 
contribute to the metastatic potential of malignant tumors 10. 
Hence, this makes biglycan a potential target protein for the 
present in silico study aimed at halting metastasis. 
In this study, molecular docking, Molecular dynamics and 
protein-protein interaction studies were employed to 
establish binding interactions of some selected 
phytocomponents against the target protein biglycan. 
MATERIALS AND METHODS 
In the present study, Molegro Virtual Docker (MVD) v 5.0 
(www.molegro.com) was used as a docking tool, along with 
this Molegro Molecular Viewer (MMV) was used for 
calculating docking score 11. MVD software requires the 
receptor and ligand coordinates which is either in Mol2 or 
PDB format. Protein- Protein docking was done with the 
help of Hex (version 8.0.0) software. Protein- ligand docking 
and Protein- Protein docking is a very useful approach to 
find the binding interaction of target protein with single or 
multiple ligands. For molecular dynamics study YASARA 
Structure (version 17.8.15) was the software of choice 12. 
AMBER14 force field13 was used for Molecular dynamic 
simulations 14.  
Protein and Ligand Preparation: 
The X-ray crystal structures of BGN (PDB ID: 2FT3) 15 and 
FAK (PDB ID: 4NY0) 16 were obtained from the Research 
Collaboratory for Structural Bioinformatics (RCSB) 
(http://www.pdb.org/) protein data bank (PDB) 17 having 
Uniprot ID P21810 and Q05397 respectively (Figure 1) and 
prepared for molecular docking simulation by removing all 
the heteroatoms (i.e., nonreceptor atoms such as water, ions, 
etc.). The crystallographic structures of these proteins were 
selected according to the maximum matched sequences 
among the protein chains available in RCSB PDB database. 
3D structures of all the 30 natural compounds from different 
culinary herbs having potential therapeutic role were used 
as ligands for this study (Figure 2) were obtained from 
PubChem database (https://pubchem.ncbi.nlm.nih.gov/) 18 
in 3D structure data format (SDF). 
  
 
Figure 1: 3D structures of Biglycan (BGN) and Focal adhesion kinase (FAK) 
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Figure 2: 3D structures of the selected phytocomponents from different culinary herbs 
 
Molecular Docking studies: 
(A) Biglycan (BGN) and Phytocomponents (Ligands): 
Molecular docking technique was employed to dock the 
selected phytocomponents against BGN using Molegro 
Virtual Docker (MVD) to locate the interaction between the 
phytocomponents and the target protein BGN. All the 30 
phytocomponents were docked against the target protein 
BGN and the compounds having minimum energy were 
selected for further study. Default settings were used for all 
the calculations.  
(B) FAK and selected phytocomponents (Ligands): 
The selected 30 phytocomponents from different culinary 
herbs were again docked against the targeted protein FAK to 
check the binding interaction of the phytocomponents with 
the protein.  
(C) BGN and FAK (Protein- Protein) Docking: 
Protein- Protein docking of BGN and FAK was done using 
Hex (version 8.0.0) protein docking software. 500 model 
structures were formed according to the interaction energy 
and bonding of the two proteins. The highest docking score 
was used for the further study.  
(D) Molecular docking of BGN-Phytocomponent 
complex with FAK and FAK-Phytocomponent 
complex with BGN: 
BGN-Phytocomponent complex and FAK-Phytocomponent 
complex were docked with FAK and BGN respectively to see 
the interaction energy of protein-ligand-protein complex 
which will be used further in the study. 
(E) Molecular dynamics simulations: 
The molecular dynamics simulation study was carried out to 
identify the changes in the structural conformation, 
interaction pattern and binding stability of BGN-
Phytocomponent-FAK and FAK-Phytocomponent-BGN 
complexes. The complex was simulated with frame capture 
at 10ns (Production Period) intervals to analyze the 
molecular dynamics (MD) trajectory.  
The default simulation parameters of YASARA Structure 
were used for the study with fixed pressure P, temperature T 
and number of atoms N (constant-NPT ensemble) with 
TIP3P (Three-site Transferrable Intermolecular Potential) 19 
water model and amber 14 force field 20.  
The pH of the simulation system by default is set as the 
physiological pH of 7.4. Furthermore the MD simulation was 
performed at temperature 298K , 1 bar pressure with ion 
concentration as a mass fraction of 0.9% NaCl ,with solvent 
density of  0.997 and at time steps of 1fs with the periodic 
boundaries wherein all the atoms present were in the 
mobile state. The molecular dynamics study was done to 
identify the stability and structural changes of the complexes 
in terms of time vs energy and time vs root mean squared 
deviation (RMSD) values 21. 
RESULTS: 
Using different in-silico tools like MVD, YASARA Structure 
(version 17.8.15) and Hex (version 8.0.0), the results 
obtained revealed a beneficial specific binding interaction 
between the target protein and phytocomponents which 
may be able to arrest metastasis by inhibiting the role of 
biglycan in the activation of FAK. 
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Molecular Docking analysis: 
(A) BGN and Phytocomponents:  
The ligands show binding affinity representing various types 
of interactions including hydrogen bond interactions, steric 
interactions and the responsible amino acid residues for 
protein-ligand interactions were His 235, Asp 237, Arg 257, 
Leu 258, Gly 259, Gly 261, His 262, Glu 281, His 283, Asp 
285. After conformation of these key amino acid residues 
with all the phytocomponents, Rosmarinic acid (RA) shows 
the highest docking score with biglycan (Table 1). The 
binding poses of Biglycan and phytocomponents (Figure 3) 
shows that there are 5 hydrogen bond interactions with RA 
and the key amino acid residues were His 235, Leu 258, His 
262, Glu 281 and Asp 285.  
 
 
Figure 3: Binding poses of phytocomponents (Ligands) with target protein Biglycan (BGN) 
Table-1: Interaction profile of Biglycan (BGN) with phytocomponents. 
Protein + Ligands 
Docking Score 
(Kcal/mol) 
H Bond Steric Interactions 
BGN -Rosmarinic acid -113.445 
His 235, Leu 258,  His 262, 
Glu 281, Asp 285  
His 235, Asp 237, Leu 258,  Gly 259, His 
262, Glu 281,His 283, Asp 285 
BGN - Manool -88.125 His 235 His 235,  Asp 237, Arg 257, Glu 281 
BGN – Citral -85.118 His 262 Arg 257, Glu 259,  His 262 
BGN – Methyl cinnamate -80.631 Gly 261 Gly 259,  Gly 261, Glu 281, His 283, 
BGN - α-humulene -80.254 Nil His 235, Arg 257,  His 283 
BGN - β-myrecene -78.601 Nil Asp 237, Gly 259, Glu 281 
BGN – Viridiflorol -78.012 Nil His 235, Arg 257,  His 283 
BGN - Linalool -76.605 His 283 Leu 258, Glu 281, His 283 
BGN - Carvacrol -69.675 Leu 258, His 283 Leu 258, Glu 281, His 283 
BGN - α-Thujone -64.804 Arg 257 His 235, Arg 257,  Gly 259, Glu 281 
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(B) FAK and Phytocomponents:  
The Molecular docking study shows that FAK is effectively 
interacting with some of the phytocomponents and the key 
amino acid residues were Leu 262, Gly 263, Ser 264, Ser 265, 
Trp 266, Ile 268, Glu 325, Pro 326, Leu 327 and Thr 328. 
Rosmarinic acid (RA) shows the highest docking score in this 
docking study also (Table 2). The key amino acid residues 
like Ser 264, Ser 265, Trp 266 and Thr 328 indicated strong 
hydrogen bond interaction with the protein FAK (Figure 4).
 
 
Figure 4: Binding poses of phytocomponents (Ligands) with Focal adhesion kinase protein (FAK) 
Table-2: Interaction profile of Focal Adhesion Kinase (FAK) with phytocomponents 
Protein – Ligands 
Docking Score 
(Kcal/mol) 
H Bond 
 
Steric Interactions 
 
FAK - Rosmarinic 
acid 
-100.771 
Ser 264, Ser 265, Trp 
266, Thr 328 
Leu 262, Gly 263, Ser 264, Ser 265, Thr 328, Leu 
327, Pro 326, Trp 266 
FAK - Manool -64.236 Glu 325 Ser 264, Ser 265, Glu 325 
FAK - Citral -98.026 NIL Gly 263, Ser 265, Leu 327 
FAK - Methyl 
cinnamate 
 
-101.138 Ser 264, Thr 328 Gly 263, Ser 264, Ser 265, Trp 266, Leu 327, Thr 328 
FAK - α-humulene 
 
-71.782 NIL Leu 262, Gly 263, Ser 264, Trp 266, Glu 325, Pro 326 
FAK - β-myrecene -91.419 NIL Gly 263, Ser 264, Trp 266, Leu 327,  
FAK - Viridiflorol -78.138 
Ser 264, Ser 265, Trp 
266,  
Leu 262, Gly 263, Ser 264, Ser 265, Trp 266, Ile 268, 
, Leu 327 
FAK - Linalool -98.327 Ser 265, Trp 266 Gly 263, Ser 264, Ser 265, Trp 266, Pro 326, Leu 327 
FAK - Carvacrol -91.076 Ser 264 Ser 264, Ser 265, Leu 327 
FAK - α-Thujone -73.190 Ser 264 Gly 263, Ser 264, Ser 265, Trp 266 
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(C) Protein- Protein docking results:  
To examine the binding interaction of biglycan and focal 
adhesion kinase, protein-protein docking was done using 
Hex (version 8.0.0) protein docking software. The result 
shows 500 model structures according to the interaction 
energy. The model which showed the highest binding 
interaction of-817.00 KJ/mol (Figure 5) was selected and 
used for further study. 
 
Figure 5: 3D structure of BGN-FAK complex 
(D) BGN-RA complex with FAK and FAK-RA complex 
with BGN:  
The Biglycan-Rosmarinic acid (BGN-RA) complex which was 
formed by the protein-ligand docking studies was then 
docked with FAK. The result shows that BGN-RA complex 
have the binding score of -763.82 KJ/ mol with the protein 
FAK. Similarly FAK-RA complex was docked with BGN and 
the interaction score noted was -815.61 KJ/ mol.  
Molecular Dynamics (MD) studies:  
The binding poses of BGN-RA complex with FAK and FAK-RA 
complex with BGN were selected for the molecular dynamics 
study, the stability of this complex structure was analyzed 
with the help of molecular dynamics study using YASARA 
software. The study was aimed at identifying the stability of 
the structure which was used for this study and to observe 
the initial and subsequent structural changes in the complex. 
The results obtained indicated stability and structural 
changes in terms of RMSD values. Figure 6(A) and Figure 
6(C) shows the MD trajectories of the complexes in Time 
(ps) vs Energy (kJ/ mol) having minimum -1835908.36 and 
maximum -1396981.43 with an average of -1403930.128 
kJ/mol energy value for BGN-RA-FAK and minimum -
1918312.348, maximum -1465364.668 and an average of -
1472015.331 kJ/mol for FAK-RA-BGN. Time (ps) vs RMSD 
values can also be seen in Figure 6(B) and Figure 6(D) 
having major peaks at 8200ps, 8300ps, 9700ps and 10000ps 
for BGN-RA-FAK complex and at 7700ps, 8600ps, 9400ps, 
9600ps and 10000ps for FAK-RA-BGN. Structural 
neighborliness relied on crystallographic protein data which 
was utilized to identify interfacial amino acids in the protein 
which play an important role in the binding interaction and 
could eventually aid in controlling metastasis. Molecular 
Dynamics (MD) simulations and interaction energy analysis 
confirmed the selectivity of compound as potential inhibitor 
based on the conformational and dynamic differences 
observed between the residues in the Protein active sites.
 
 
Figure 6: A: MD Trajectories of BGN-RA-FAK complex showing Time (ps) vs Energy (kJ/ mol) 
B: MD Trajectories of BGN-RA-FAK complex showing Time (ps) vs RMSD 
C: MD Trajectories of FAK-RA-BGN complex showing Time (ps) vs Energy (kJ/ mol) 
D: MD Trajectories of FAK-RA-BGN complex showing Time (ps) vs RMSD 
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DISCUSSION: 
Metastasis is one of the major causes of mortality in patients 
affected with lung cancer. One of the important factors of 
metastasis is the orientation and composition of matrix 
proteins. High amounts of some of these proteins favor 
resistance for tumor cell migration, while some other 
proteins and organized oriented depositions can promote 
tumor cell migration. Conversely, direct cell contacts 
between tumor cells and fibroblasts can also create a 
migratory-inhibitory matrix which is composed of 
unorganized collagens and proteoglycans 22. Recently, 
Maishi and Hida 23 observed that in highly metastatic 
tumors, endothelial cells interact with tumor cells by 
secretion of a small leucine-rich repeat proteoglycan known 
as biglycan. Biglycan from tumor endothelial cells stimulates 
the tumor cells to metastasize by activating the FAK 
signaling pathway. FAK protein in tumors is therefore 
associated with increased rates of migration and invasion 24, 
25. An in-depth study by Megison et al. 26, suggested that the 
inhibition of FAK resulted in decreased cellular migration 
and invasion in neuroblastoma cell lines with decreased 
metastasis in a murine model. Zhao and Guan 27 have also 
explained that inhibition of FAK activity also regulates 
motility and cell adhesion by imparting extracellular matrix 
(ECM) signals from integrins to the intracellular 
compartment. 
In the present study, selected phytocomponents from 
different culinary herbs manifested effective binding with 
Biglycan and FAK which seems to be potent in arresting the 
metastasis by inhibiting the role of the target protein 
Biglycan in the activation of FAK. These findings suggest that 
the selected phytocomponents could prove useful in 
therapeutics as blockers of key molecules that trigger 
metastasis. It is well known that medicinal plants are used in 
many countries as an alternative to synthetic drugs. 
Scientists are currently working towards identifying herbal 
extracts which could act as an active agent, to overcome 
world health issues 28. These medicinal plants are rich 
source of phytochemicals and secondary metabolites which 
have been used in traditional medicine and as chemical 
entities for modern drugs. The medicinal value of the plant 
depends upon the presence of specific phytochemical 
components which bring about particular physiological 
effects in the human body. Research carried out by Ozlem et 
al., 29 shows that the herb rosemary can inhibit the initiation 
and tumor progression stages in mice models. Hence in the 
present study, certain medicinal herbs like rosemary, sage, 
parsley, thyme and basil were selected, based on their 
potential medicinal properties. 
In this study, 30 phytocomponents from rosemary, thyme, 
parsley, sage and basil were selected to evaluate their 
potential to inhibit biglycan so as to block the activation of 
the FAK signaling pathway and in turn, arrest metastasis in 
non-small cell lung cancer. Amongst these 30 
phytocomponents, ten were selected according to their 
binding interactions with the protein for further studies with 
the protein complex. 
According to the results obtained in the present 
investigation, Rosmarinic acid (RA) gave the highest docking 
score with biglycan and FAK hence it was selected for the 
molecular dynamics study. Rosmarinic acid (RA) is an 
abundant phenolic ester found in Rosemary (Rosmarinus 
officinalis), Thyme (Thymus vulgaris), Basil (Ocimum 
basilicum) and Sage (Salvia officinalis) which has been used 
in oriental medicine 30, 31. Many studies have reported that 
RA possesses variety of biological effects including anti-
inflammatory, anti-diabetic, and anti-cancer activities32. In a 
study by Xu et al. 33, it has been reported that Rosmarinic 
acid inhibited bone metastasis induced by breast cancer, 
which was substantiated in a further study 34. 
Analysis of binding energy values for Rosmarinic acid 
yielded the highest docking score as compared to other 
phytocomponents. Molecular docking study of BGN-RA 
complex with FAK showed a binding interaction of -763.82 
KJ/ mol which is less than the binding score of BGN-FAK 
complex which indicated that the phytocomponent 
rosmarinic acid effectively inhibits the interaction of BGN 
with FAK. The interaction energy of FAK-RA complex with 
BGN suggests the converse as the interaction energy is 
higher than that of the BGN-RA complex with FAK complex, 
which reveals that in the presence of this specific 
phytocomponent, its interaction and binding affinity is 
greater towards BGN. Consequently, it does not bind 
strongly with FAK. Molecular dynamics of these complexes 
showed the initial and subsequent changes in structure in 
terms of RMSD values. The stability of the BGN-RA with FAK 
complex shows that the phytocomponent interaction can 
inhibit the binding of BGN with FAK, hence activation of focal 
adhesion kinase will be impaired and thus metastasis can be 
controlled. 
This study therefore provides evidence that Rosmarinic acid 
could block the binding interaction of BGN to FAK and 
consequently impair the activation of FAK signaling, which 
in turn, would effectively inhibit metastasis. This molecule 
would therefore prove to be of immense significance in 
controlling metastasis in Non- small cell lung cancer. 
CONCLUSION:  
Molecular dynamics simulations and interaction energy 
analysis confirmed the selectivity of Rosmarinic acid (RA) as 
potential inhibitor based on the conformational and dynamic 
differences observed between the residues in the Protein 
active sites. Investigating the binding interactions of BGN-
RA-FAK complex prove significant in inhibiting the 
interaction of BGN to FAK which can efficiently arrest 
metastasis in NSCLC.  
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